Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1993 Feb 11;21(3):695–702. doi: 10.1093/nar/21.3.695

Identification of a cis acting element responsible for muscle specific expression of the c-mos protooncogene.

J L Lenormand 1, M Guillier 1, S A Leibovitch 1
PMCID: PMC309171  PMID: 8441678

Abstract

A series of deletion constructs of the 5' flanking region of rat c-mos gene was positioned upstream to the CAT gene and transfected into muscle and non-muscle cells. CAT activities revealed that a region located downstream of a TATA box and containing the proximal transcription start site is the muscle c-mos promoter. This promoter is more efficient in L6 alpha 1 myoblasts than in L6 alpha 1 myotubes but not in C3H10T1/2 cells. Gel shift assays demonstrated that nuclear proteins from myoblasts and myotubes formed complexes migrating differently. Footprinting analyses showed that nuclear proteins from L6 alpha 1 myoblasts protected a DNA fragment located at position nt -979 to nt -938 relative to the first ATG of the rat c-mos ORF while nuclear proteins from myotubes protected the DNA between nt -998 to nt -928. Furthermore one of protein - DNA complexes containing the proximal transcription start site, included a consensus sequence TGTC(AGT/TCG)CC(A/T)G present in the initiator element (Inr) of several genes. Southwestern blot analysis pointed to a 82kDa polypeptide as a potential candidate for trans acting factor in myoblasts. In L6 alpha 1 myotubes this polypeptide is replaced by other proteins of 40-42kDa and 82kDa. An interplay between these two complexes may constitute a developmental as well as a physiologically regulated mechanism that modulates c-mos expression during the early stages of myogenesis.

Full text

PDF
695

Images in this article

698Image
on p.698
698Image
on p.698
698Image
on p.698
700Image
on p.700
701Image
on p.701

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayer D. E., Dynan W. S. A downstream-element-binding factor facilitates assembly of a functional preinitiation complex at the simian virus 40 major late promoter. Mol Cell Biol. 1990 Jul;10(7):3635–3645. doi: 10.1128/mcb.10.7.3635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beaupain D., Eléouët J. F., Roméo P. H. Initiation of transcription of the erythroid promoter of the porphobilinogen deaminase gene is regulated by a cis-acting sequence around the cap site. Nucleic Acids Res. 1990 Nov 25;18(22):6509–6515. doi: 10.1093/nar/18.22.6509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Biggin M. D., Tjian R. Transcription factors that activate the Ultrabithorax promoter in developmentally staged extracts. Cell. 1988 Jun 3;53(5):699–711. doi: 10.1016/0092-8674(88)90088-8. [DOI] [PubMed] [Google Scholar]
  4. Caravatti M., Minty A., Robert B., Montarras D., Weydert A., Cohen A., Daubas P., Buckingham M. Regulation of muscle gene expression. The accumulation of messenger RNAs coding for muscle-specific proteins during myogenesis in a mouse cell line. J Mol Biol. 1982 Sep;160(1):59–76. doi: 10.1016/0022-2836(82)90131-0. [DOI] [PubMed] [Google Scholar]
  5. Celenza J. L., Carlson M. A yeast gene that is essential for release from glucose repression encodes a protein kinase. Science. 1986 Sep 12;233(4769):1175–1180. doi: 10.1126/science.3526554. [DOI] [PubMed] [Google Scholar]
  6. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frebourg T., Brison O. Plasmid vectors with multiple cloning sites and cat-reporter gene for promoter cloning and analysis in animal cells. Gene. 1988 May 30;65(2):315–318. doi: 10.1016/0378-1119(88)90468-4. [DOI] [PubMed] [Google Scholar]
  8. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gunning P., Hardeman E., Wade R., Ponte P., Bains W., Blau H. M., Kedes L. Differential patterns of transcript accumulation during human myogenesis. Mol Cell Biol. 1987 Nov;7(11):4100–4114. doi: 10.1128/mcb.7.11.4100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Herzog N. K., Ramagli L. S., Khorana S., Arlinghaus R. B. Evidence for somatic cell expression of the c-mos protein [corrected]. Oncogene. 1989 Nov;4(11):1307–1315. [PubMed] [Google Scholar]
  11. Kurata N., Akiyama H., Taniyama T., Marunouchi T. Dose-dependent regulation of macrophage differentiation by mos mRNA in a human monocytic cell line. EMBO J. 1989 Feb;8(2):457–463. doi: 10.1002/j.1460-2075.1989.tb03398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Leibovitch M. P., Leibovitch S. A., Harel J., Kruh J. Changes in the frequency and diversity of messenger RNA populations in the course of myogenic differentiation. Eur J Biochem. 1979 Jul;97(2):321–326. doi: 10.1111/j.1432-1033.1979.tb13117.x. [DOI] [PubMed] [Google Scholar]
  14. Leibovitch M. P., Leibovitch S. A., Hillion J., Guillier M., Schmitz A., Harel J. Possible role of c-fos, c-N-ras and c-mos proto-oncogenes in muscular development. Exp Cell Res. 1987 May;170(1):80–92. doi: 10.1016/0014-4827(87)90118-2. [DOI] [PubMed] [Google Scholar]
  15. Leibovitch S. A., Guillier M., Lenormand J. L., Leibovitch M. P. Accumulation of the c-mos protein is correlated with post-natal development of skeletal muscle. Oncogene. 1991 Sep;6(9):1617–1622. [PubMed] [Google Scholar]
  16. Leibovitch S. A., Lenormand J. L., Leibovitch M. P., Guiller M., Mallard L., Harel J. Rat myogenic c-mos cDNA: cloning sequence analysis and regulation during muscle development. Oncogene. 1990 Aug;5(8):1149–1157. [PubMed] [Google Scholar]
  17. Lorca T., Galas S., Fesquet D., Devault A., Cavadore J. C., Dorée M. Degradation of the proto-oncogene product p39mos is not necessary for cyclin proteolysis and exit from meiotic metaphase: requirement for a Ca(2+)-calmodulin dependent event. EMBO J. 1991 Aug;10(8):2087–2093. doi: 10.1002/j.1460-2075.1991.tb07741.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Minty A. J., Caravatti M., Robert B., Cohen A., Daubas P., Weydert A., Gros F., Buckingham M. E. Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA. J Biol Chem. 1981 Jan 25;256(2):1008–1014. [PubMed] [Google Scholar]
  19. Mutter G. L., Wolgemuth D. J. Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5301–5305. doi: 10.1073/pnas.84.15.5301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. O'Shea-Greenfield A., Smale S. T. Roles of TATA and initiator elements in determining the start site location and direction of RNA polymerase II transcription. J Biol Chem. 1992 Jan 15;267(2):1391–1402. [PubMed] [Google Scholar]
  21. Ogiso Y., Matsumoto M., Morita T., Nishino H., Iwashima A., Matsushiro A. Expression of c-mos proto-oncogene in undifferentiated teratocarcinoma cells. Biochem Biophys Res Commun. 1986 Oct 30;140(2):477–484. doi: 10.1016/0006-291x(86)90757-6. [DOI] [PubMed] [Google Scholar]
  22. Oskarsson M., McClements W. L., Blair D. G., Maizel J. V., Vande Woude G. F. Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science. 1980 Mar 14;207(4436):1222–1224. doi: 10.1126/science.6243788. [DOI] [PubMed] [Google Scholar]
  23. Pal S. K., Zinkel S. S., Kiessling A. A., Cooper G. M. c-mos expression in mouse oocytes is controlled by initiator-related sequences immediately downstream of the transcription initiation site. Mol Cell Biol. 1991 Oct;11(10):5190–5196. doi: 10.1128/mcb.11.10.5190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Propst F., Rosenberg M. P., Iyer A., Kaul K., Vande Woude G. F. c-mos proto-oncogene RNA transcripts in mouse tissues: structural features, developmental regulation, and localization in specific cell types. Mol Cell Biol. 1987 May;7(5):1629–1637. doi: 10.1128/mcb.7.5.1629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Propst F., Rosenberg M. P., Oskarsson M. K., Russell L. B., Nguyen-Huu M. C., Nadeau J., Jenkins N. A., Copeland N. G., Vande Woude G. F. Genetic analysis and developmental regulation of testis-specific RNA expression of Mos, Abl, actin and Hox-1.4. Oncogene. 1988 Mar;2(3):227–233. [PubMed] [Google Scholar]
  26. Propst F., Vande Woude G. F. Expression of c-mos proto-oncogene transcripts in mouse tissues. Nature. 1985 Jun 6;315(6019):516–518. doi: 10.1038/315516a0. [DOI] [PubMed] [Google Scholar]
  27. Prussak C. E., Almazan M. T., Tseng B. Y. Mouse primase p49 subunit molecular cloning indicates conserved and divergent regions. J Biol Chem. 1989 Mar 25;264(9):4957–4963. [PubMed] [Google Scholar]
  28. Roeder R. G. The complexities of eukaryotic transcription initiation: regulation of preinitiation complex assembly. Trends Biochem Sci. 1991 Nov;16(11):402–408. doi: 10.1016/0968-0004(91)90164-q. [DOI] [PubMed] [Google Scholar]
  29. Sagata N., Oskarsson M., Copeland T., Brumbaugh J., Vande Woude G. F. Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature. 1988 Oct 6;335(6190):519–525. doi: 10.1038/335519a0. [DOI] [PubMed] [Google Scholar]
  30. Sagata N., Watanabe N., Vande Woude G. F., Ikawa Y. The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature. 1989 Nov 30;342(6249):512–518. doi: 10.1038/342512a0. [DOI] [PubMed] [Google Scholar]
  31. Schmidt M., Oskarsson M. K., Dunn J. K., Blair D. G., Hughes S., Propst F., Vande Woude G. F. Chicken homolog of the mos proto-oncogene. Mol Cell Biol. 1988 Feb;8(2):923–929. doi: 10.1128/mcb.8.2.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Smale S. T., Baltimore D. The "initiator" as a transcription control element. Cell. 1989 Apr 7;57(1):103–113. doi: 10.1016/0092-8674(89)90176-1. [DOI] [PubMed] [Google Scholar]
  33. Smale S. T., Schmidt M. C., Berk A. J., Baltimore D. Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4509–4513. doi: 10.1073/pnas.87.12.4509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Soeller W. C., Poole S. J., Kornberg T. In vitro transcription of the Drosophila engrailed gene. Genes Dev. 1988 Jan;2(1):68–81. doi: 10.1101/gad.2.1.68. [DOI] [PubMed] [Google Scholar]
  35. Watanabe N., Vande Woude G. F., Ikawa Y., Sagata N. Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs. Nature. 1989 Nov 30;342(6249):505–511. doi: 10.1038/342505a0. [DOI] [PubMed] [Google Scholar]
  36. Wood T. G., McGeady M. L., Baroudy B. M., Blair D. G., Vande Woude G. F. Mouse c-mos oncogene activation is prevented by upstream sequences. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7817–7821. doi: 10.1073/pnas.81.24.7817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yaffe D. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci U S A. 1968 Oct;61(2):477–483. doi: 10.1073/pnas.61.2.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zinkel S. S., Pal S. K., Szeberényi J., Cooper G. M. Identification of a negative regulatory element that inhibits c-mos transcription in somatic cells. Mol Cell Biol. 1992 May;12(5):2029–2036. doi: 10.1128/mcb.12.5.2029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. van der Hoorn F. A., Hulsebos E., Berns A. J., Bloemers H. P. Molecularly cloned c-mos(rat) is biologically active. EMBO J. 1982;1(11):1313–1317. doi: 10.1002/j.1460-2075.1982.tb01316.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. van der Hoorn F. A. Identification of the testis c-mos promoter: specific activity in a seminiferous tubule-derived extract and binding of a testis-specific nuclear factor. Oncogene. 1992 Jun;7(6):1093–1099. [PubMed] [Google Scholar]
  41. van der Hoorn F. A., Müller V., Pizer L. I. Sequences upstream of c-mos(rat) that block RNA accumulation in mouse cells do not inhibit in vitro transcription. Mol Cell Biol. 1985 Feb;5(2):406–409. doi: 10.1128/mcb.5.2.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. van der Hoorn F. A., Neupert B. The repressor sequence upstream of c-mos acts neither as polyadenylation site nor as transcription termination region. Nucleic Acids Res. 1986 Nov 25;14(22):8771–8783. doi: 10.1093/nar/14.22.8771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. van der Hoorn F. A., Nordeen S. K. An enhancer in the c-mos locus binds a nuclear factor 1-like protein. Biochem Biophys Res Commun. 1989 May 30;161(1):8–15. doi: 10.1016/0006-291x(89)91552-0. [DOI] [PubMed] [Google Scholar]
  44. van der Hoorn F. A. c-mos upstream sequence exhibits species-specific enhancer activity and binds murine-specific nuclear proteins. J Mol Biol. 1987 Jan 20;193(2):255–266. doi: 10.1016/0022-2836(87)90217-8. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES